{
 "PrintNo":"S2387","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-20T10:32:52.102892Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-01-20","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1228,"Name":"Zellnor Myrie","Short":"MYRIE"}],
 "Title":"Relates to investigating critical prescription drug pricing",
 "Summary":"Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.",
 "LawSection":"Insurance Law","LawCode":"Add ยง346, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to investigating critical prescription drug pricing",
 "PreviousVersions":["S7739-2019","S320-2021"]
}